Interferon alpha-2b and thalidomide in previously treated patients with disseminated malignant melanoma: SWOG 0026.

被引：0
|
作者：
Hutchins, L
Moon, J
Clark, J
Thompson, J
Yost, K
Sondak, V
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] SW Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Grand Rapids CCOP, Grand Rapids, MI USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：716S / 716S
页数：1
相关论文
共 50 条
  • [41] Phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high-risk melanoma (SWOG S0008): An intergroup study of CALGB, COG, ECOG, and SWOG.
    Flaherty, Lawrence E.
    Moon, James
    Atkins, Michael B.
    Tuthill, Ralph
    Thompson, John A.
    Vetto, John T.
    Haluska, Frank G.
    Pappo, Alberto S.
    Sosman, Jeffrey Alan
    Redman, Bruce G.
    Ribas, Antoni
    Kirkwood, John M.
    Sondak, Vernon K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] EFFICACY AND TOLERANCE OF ALPHA-2B INTERFERON THERAPY ON HCV INFECTION OF HEMODIALYZED PATIENTS
    POL, S
    THIERS, V
    CARNOT, F
    ZINS, B
    ROMEO, R
    BERTHELOT, P
    BRECHOT, C
    KIDNEY INTERNATIONAL, 1995, 47 (05) : 1412 - 1418
  • [43] POSSIBLE SELECTIVE EFFECTS OF INTERFERON ALPHA-2B ON A MALIGNANT CLONE IN A CASE OF POLYCYTHEMIA-VERA
    HINO, M
    FUTAMI, E
    OKUNO, S
    MIKI, T
    NISHIZAWA, Y
    MORII, H
    ANNALS OF HEMATOLOGY, 1993, 66 (03) : 161 - 162
  • [44] INTERFERON ALPHA-2B AS THERAPY FOR PATIENTS WITH PH'-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    ALIMENA, G
    MORRA, E
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    INVERARDI, D
    BERNASCONI, P
    MANCINI, M
    DONTI, E
    GRIGNANI, F
    BERNASCONI, C
    DIANZANI, F
    MANDELLI, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 : 25 - 28
  • [45] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Mukherjee, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 727 - 727
  • [46] INVESTIGATIONS ON THE SUBCLINICAL AND CLINICAL NEPHROTOXICITY OF INTERFERON ALPHA-2B IN PATIENTS WITH MYELOPROLIFERATIVE SYNDROMES
    KURSCHEL, E
    METZKURSCHEL, U
    NIEDERLE, N
    AULBERT, E
    RENAL FAILURE, 1991, 13 (2-3) : 87 - 93
  • [47] Treatment with interferon alpha-2b in haemophiliac patients infected with hepatitis C virus
    Quintana, M
    Canales, M
    Jimenez-Yuste, V
    Villar, A
    Morado, M
    Gago, J
    Sanjurjo, MJ
    Magallon, M
    Hernandez-Navarro, F
    THROMBOSIS AND HAEMOSTASIS, 1999, : 789 - 790
  • [48] RECOMBINANT INTERFERON ALPHA-2B IN PATIENTS WITH PROGRESSIVE AND OR RECURRENT HODGKINS-DISEASE
    ARDAIZ, MD
    NIBORSKI, R
    KOZINER, B
    LEUKEMIA & LYMPHOMA, 1991, 3 (5-6) : 439 - 441
  • [49] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Lebovics, E
    Dieterich, DI
    Esposito, SP
    Bach, N
    Klion, F
    Tobias, H
    Antignano, L
    Brown, RS
    Gabbaizadeh, D
    Geders, J
    Levendoglu, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1700 - 1705
  • [50] ANTIBODIES IN PATIENTS WITH HAIRY-CELL LEUKEMIA RECEIVING ALPHA-2B INTERFERON
    JACOBS, SL
    KELSEY, DK
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (22): : 1418 - 1418
12345